ArticleFrontiers in immunology2022

Multiple SARS-CoV-2 Variants Exhibit Variable Target Cell Infectivity and Ability to Evade Antibody Neutralization.

Haijun Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.